Neuroone Medical Technologies (NMTC) Net Income Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.19% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 343.24% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 60.12% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.38% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn | 16.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.03% |
| Dec 31, 2025 | 6.03% |
| Sep 30, 2025 | -5.62% |
| Jun 30, 2025 | 18.37% |
| Mar 31, 2025 | 9.45% |
| Dec 31, 2024 | 38.14% |
| Sep 30, 2024 | -8.21% |
| Jun 30, 2024 | 2.12% |
| Mar 31, 2024 | -6.05% |
| Dec 31, 2023 | -19.51% |
| Sep 30, 2023 | -31.69% |
| Jun 30, 2023 | 21.21% |
| Mar 31, 2023 | -37.82% |
| Dec 31, 2022 | 27.97% |
| Sep 30, 2022 | -0.51% |
| Jun 30, 2022 | -14.00% |
| Mar 31, 2022 | -11.40% |
| Jun 30, 2021 | -36.05% |
| Mar 31, 2021 | -29.69% |
| Dec 31, 2020 | -36.30% |
| Sep 30, 2020 | 143.12% |
| Jun 30, 2019 | -460.30% |
| Mar 31, 2019 | -719.77% |
| Jun 30, 2018 | -593.14% |
| Mar 31, 2018 | -355.89% |
| Jun 30, 2016 | 17.88% |
| Mar 31, 2016 | -6.67% |
| Dec 31, 2015 | -92.98% |
| Sep 30, 2015 | -16.08% |
| Jun 30, 2015 | -14.40% |
| Mar 31, 2015 | -27.61% |
| Jun 30, 2014 | -135.92% |
| Mar 31, 2014 | 14.19% |
| Dec 31, 2013 | -67.77% |
| Sep 30, 2013 | 5.92% |